Basic information
Generic Drug
Route of Administration
Strength / Concentration
Presentation and price
10 ml vial
30 ml vial
Dose and dosage
1.25-2.50ml/100kg body weight once/twice/thrice daily
1.25-2.50ml/100kg body weight
1.25-2.50ml/100kg body weight
1ml/40kg body weight
1ml/40kg body weight
1ml/20kg body weight
0.1ml/2kg body weight
-----
Antihistamines used as antiemetics are administered for motion sickness, vomiting induced by chemotherapy, and GI disease that stimulates vomiting. Antihistamines are not effective antiemetics for cats. They may be effective in some dogs; however, there are other antiemetics available for dogs and cats that are consistently more effective.
Antimuscarinic effects (atropine-like effects) are common. Do not use in conditions for which anticholinergic drugs may be contraindicated, such as glaucoma, ileus, or cardiac arrhythmias. Do not administer to patients in which theophylline products are contraindicated.
Antihistamine (H1-blocker). Diphenhydramine is the active moiety of dimenhydrinate. The pharmacologic properties are the same as diphenhydramine. Dimenhydrinate contains diphenhydramine and chlortheophylline. Dimenhydrinate is a salt consisting of 53.0%–55.5% diphenhydramine and 44.0%–46.5% 8-chlorotheophylline. In people, it is used for treatment of nausea, dizziness, and vomiting associated with motion sickness. Diphenhydramine produces the antinausea effects, and chlorotheophylline, a methylxanthine derivative related to caffeine, is added to reduce drowsiness. Similar to other antihistamines, diphenhydramine acts by blocking the H1 receptor and suppresses inflammatory reactions caused by histamine. The H1 blockers have been used to control pruritus and skin inflammation in dogs and cats; however, success rates in dogs have not been high. Commonly used antihistamines include clemastine, chlorpheniramine, diphenhydramine, and hydroxyzine. Diphenhydramine also has central-acting antiemetic properties, possibly by acting on the vomiting center or via the chemoreceptor-trigger zone (CRTZ).
Pharmacokinetics: The oral bioavailability of diphenhydramine is much higher when administered as the dimenhydrinate salt—as much as 50–70 times in some studies. Diphenhydramine oral bioavailability is 22% in dogs when administered as dimenhydrinate but only 8% when administered alone. The terminal half-life of diphenhydramine from this formulation in dogs is 12 hours. The theophylline component in this formulation is also absorbed and attains levels that can be considered to have therapeutic effects.
ANTICHOLINERGIC DRUGS (including tricyclic antidepressants): Diphenhydramine may potentiate anticholinergic effects
CNS DEPRESSANT DRUGS: Increased sedation can occur
The most commonly seen adverse effects are CNS depression (lethargy, somnolence), and anticholinergic effects (dry mouth, urinary retention). The sedative effects of antihistamines may diminish with time. GI effects (diarrhea, vomiting, anorexia) are a possibility.
The sedative effects of antihistamines may adversely affect the performance of working dogs. Diphenhydramine may cause paradoxical excitement in cats. The liquid formulation is very distasteful.
Overdosage can cause CNS stimulation (excitement to seizures) or depression (lethargy to coma), anticholinergic effects, respiratory depression and death. Treatment consists of emptying the gut after oral ingestion using standard protocols. Induce emesis if the patient is alert and CNS status is stable. Administration of a saline cathartic and/or activated charcoal may be given after emesis or gastric lavage. Treatment of other clinical signs should be performed using symptomatic and supportive therapies. Phenytoin (IV) is recommended in the treatment of seizures caused by antihistamine overdose in humans; barbiturates and diazepam should be avoided.
Meat: 7 days
Milk: 2 days